
'King Kong' of weight loss jabs available on NHS to those in need from today
Around 220,000 people with "greatest need" are expected to receive Mounjaro, also known as tirzepatide and made by Lilly through the NHS over the next three years
Hundreds of thousands of NHS patients will benefit from the 'King Kong' of weight loss jabs from today. Around 220,000 in "greatest need" are expected to receive Mounjaro in the mass roll out over the next three years. It is the brand name for the drug tirzepatide, orginally an antidiabetic treatment which lowers blood sugar and slows down how quickly food is digested.
GPs in England are being allowed to prescribe Mounjaro to severely obese people for the first time. Patients needed to be on weight loss programmes to get the drug previously. It will initially be offered to people with a body mass index (BMI) score of over 40 in the first year of the roll out.
They will also have conditions such as type 2 diabetes; high blood pressure; heart disease; and obstructive sleep apnoea. Around 1.5m already take weight loss drugs in the UK, often through specialist weight loss services or via private prescription.
Dr Claire Fuller, from NHS England, said: "This is an important next step in the rollout of weight loss drugs, with community-based services now able to offer this treatment from today. We urgently need to address rising levels of obesity and prioritise support for those who are experiencing severe ill health and greater access to weight loss drugs will make a significant difference to the lives of those people.
"These drugs are an important tool alongside the range of wraparound NHS support and advice on good nutrition and increasing physical activity.
"They will be vital in helping some people lose weight and reduce their risk of serious long-term conditions."
Anyone worried about their weight was urged to still speak with GPs and seek advice even if they were not eligible for the drug. Professor Kamila Hawthorne, chairwoman of the Royal College of GPs, said: "We recognise the potential benefits of weight loss drugs.
"But we know many GPs are concerned about the implications of the rollout of weight loss drugs into general practice, both in terms of workload and training to appropriately initiate and manage these treatments.
"The college shares these concerns, which is why we were pleased NHS England suggested a phased roll-out of Mounjaro as a treatment for weight loss.
"As and when this is escalated, appropriate resourcing for general practice, including access to 'wraparound' services, and training for GPs must follow."
She added: "GPs and our teams are already working under intense workload and workforce pressures, and this must be factored into this rollout in order to guarantee it can be delivered safely.
"More widely, whilst weight loss medications have a lot of potential benefits for patients who are struggling to lose weight and who meet all the clinical criteria for a prescription, they mustn't be seen as a 'silver bullet' to aid weight loss.
"We also need to focus on stopping people becoming overweight in the first place so they don't require medical intervention later."
The rollout of the jabs should not "come at the expense of other weight loss services", she added. Olivier Picard, chairman of the National Pharmacy Association, told how demand for weight loss jabs continued to rise sharply. More GPs have been directing patients to local chemists to access these treatments privately.
"We expect to see prescription volumes increase rapidly," he added. "However, NHS provision won't meet demand straight away, so we fully expect that many people will continue seeking it privately from a pharmacy. Pharmacists are experts in medication and many of us have lots of experience delivering weight loss injections as part of a package of care including lifestyle advice.
"We are well placed to help roll out weight loss treatment on the NHS, with the right funding to support it.
"The biggest concern we have is that prescribing these medications alone misses the point. They should be part of a comprehensive weight management strategy combining lifestyle coaching, exercise, and nutritional guidance.
"In reality, many GPs lack the bandwidth to deliver the level of support needed to ensure proper understanding and follow-up.
"As a result, we could end up in a situation where patients are prescribed the medication, lose weight, and then experience rebound weight gain once the course ends, simply because the foundational lifestyle changes weren't addressed." Around 29 percent of the adult population in the UK is obese.
Health Secretary Wes Streeting warned that it is now one of the leading causes of ill health, costing the NHS billions. "Yet we now have the science, technology, and knowledge to end the obesity epidemic, if we seize this opportunity," he added.
"Obesity jabs are used by 1.5 million people in the UK, mainly through private prescriptions. The NHS was founded on a promise to 'universalise the best'. We are determined to bring revolutionary modern treatments to everyone who needs them, not just those who can afford to pay."
Why it works:
Mounjaro is being rolled out gradually to those in greatest need following its success on the open market.
It contains the drug Tirzepatide which not only helps the obese to lose weight, but reduces risk of other health conditions. The fall in the number of stroke and heart attack victims should save the NHS billions in the long term.
Mounjaro is administered through a weekly injection. It was originally developed as a treatment for people with Type 2 diabetes.
Regulators authorised its use for weight loss in November 2023 in a bid to tackle obesity. Tirzepatide acts in the same way as hormones GIP and GLP-1. They are produced in the intestine after eating and make you feel full.
They also slow the passage of food through the gut which means patients feel satisfied for longer. Mounjaro 'pens' are for the abdomen or thighs if injecting yourself or the back of the upper arms if someone else is giving you the jab.
Experts stress that it is not a 'miracle' drug and ideally needs to be combined with a reduced-calorie diet and exercise. It could potentially be prescribed for 3.4m in England over time. Side effects include nausea, diarrhoea, vomiting, constipation and indigestion.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mirror
38 minutes ago
- Daily Mirror
Dermot Murnaghan had huge career news just weeks before Stage 4 cancer diagnosis
Dermot Murnaghan received a big career boost weeks before he announced his devastating cancer diagnosis and dropped hints that he was very unwell last month. The former Sky News anchor shared the news on social media today, announcing his is battling Stage 4 prostate cancer. The broadcaster took to X, previously known as Twitter, this afternoon to say he is fighting the disease and made a plea to his followers after going public for the first time. But as he was preparing to tell the world something serious was wrong, he was given something to lift him - Radio News Hub announced he was to front a brand-new weekly radio series: Dermot Murnaghan's Legends of News. Back in May, he spoke about the inspiration behind the series, why he said yes and spoke of his health issues. Dermot said: 'My personal motivation for launching Legends has been stepping off the daily news wheel myself after 40 odd years before the mast and now fighting a health battle. Instead of attempting a probably little read memoir, I decided to speak to those Legends – the colleagues and rivals that I've worked with over those decades – and tease out the stories of the mad world of broadcast news when it was in its pomp before it is subsumed by the new modes of communication.' The broadcaster made the cancer announcement today, and urged people to get themselves tested. After taking to his various social media platforms, fans, colleagues and friends made sure Dermot knew he wasn't taking on the disease on his own. In a statement shared earlier, the TV veteran confirmed his diagnosis, saying: "Some personal news……I've been diagnosed with Stage IV advanced prostate cancer I'm fortunate to have a simply outstanding medical team looking after me, who I can't thank enough - they are administering the best possible care with expertise, compassion and sensitivity. "I'm responding positively to their excellent treatment and feeling well. I'm blessed to be fortified by the monumental love and support of my wife, family and close friends. Needless to say, my message to all men over 50, in high-risk groups, or displaying symptoms, is get yourself tested and campaign for routine prostate screening by the NHS." Since sharing the news, former colleagues, famous faces and social media followers have rushed to send their support. Scriptwriter Kathleen Beedles said: "I'm so sorry to hear this. Sending you love and all the best for your healing journey. I've always loved your work. Thank you for raising awareness and thinking of others at this difficult personal time." He replied: "Ah thanks Kathleen, I feel that all the enormous support I'm getting is a big part of that journey." Sky's Breakfast Editor, Thomas Newton added: "Really sorry to hear that, Dermot. But of course, true to form, jumping straight on the bike love that. Hope the ride goes well." Responding to Thomas, Dermot stated he won't be beaten by the cruel disease, saying: "Ha! I can't take this lying down - I'm following @chrishoy's example (albeit at a hugely slower pace). Thanks, Thomas." Prostate Cancer UK states that most men with the cancer don't have any signs or symptoms of the disease. However, noticing changes in the way a man urinates is a likely indication of an enlarged prostate, but they still recommend having it checked out. They add that symptoms include difficulty when starting to urinate or emptying the bladder, weak flow when urinating, a feeling that the bladder may not be empty, dribbling after urinating, needing to urinate more often at night and the sudden urge to urinate and occasional leaks before reaching the toilet. Advanced prostate cancer can present symptoms such as back pain, hip pain or pelvis pain, problems getting or keeping an erection, blood in urine or semen and unexplained weight loss. The Macmillan Support Line offers confidential support to people living with cancer and their loved ones. If you need to talk, call us on 0808 808 0000*


BBC News
39 minutes ago
- BBC News
Shropshire maternity campaigner welcomes national inquiry
The announcement of an investigation into maternity care in England has been welcomed by a bereaved mother who has been campaigning for safety improvements for more than a Davies, who lost her daughter Kate in 2009 due to mistakes made by the Shrewsbury and Telford Hospital Trust (SATH), said: "It's clear that [Health Secretary] Wes Streeting has listened to the families."But while backing the inquiry, which was announced on Monday, she sounded a note of caution, stating that change must ultimately come from "clinicians on the ground".The probe is to look at some of the the worst-performing maternity and neonatal services, and report back in December. Prior to the announcement, Streeting met parents who lost babies in a series of maternity scandals at various NHS trusts. He said the investigation would "make sure these families get the truth and the accountability they deserve".Ms Davies, who now lives in Hereford, was involved in those discussions last week, and said the proposals he showed to the families then were "very very different" to what emerged on Monday."He clearly listened to us when we told him that what he was proposing was nowhere near enough," she said, adding Streeting was "on the side of" did, though, suggest bereaved parents in Scotland, Wales and Northern Ireland were likely to feel disappointed by the focus on Davies's daughter Kate was six hours old when she died. A campaign by Ms Davies and Kate's father Richard Stanton culminated in the Ockenden Review of maternity care at SATH, which concluded catastrophic and repeated failures led to the deaths of more than 200 babies. Making the announcement on Monday, Streeting apologised on behalf of the NHS to those families who had suffered avoidable comes after a series of maternity scandals including those in East Kent, Nottingham and Shrewsbury and inquiry will initially review up to 10 maternity and neonatal units, the identity of which has yet to be decided, although it was confirmed University Hospitals Sussex and Leeds would feature. Ms Davies said that based on discussions, she expected a "national maternity and neonatal taskforce" to be chaired by stated that such development encouraged her that families were being was different, she said, to 2009, when she first started her fight - a campaign which had led to this point, she added. Follow BBC Shropshire on BBC Sounds, Facebook, X and Instagram.


Telegraph
an hour ago
- Telegraph
Dermot Murnaghan reveals stage four prostate cancer diagnosis
Dermot Murnaghan has revealed he has been diagnosed with stage four prostate cancer. In a statement on X, the former Sky News presenter and host of BBC Breakfast said that he had been 'fortified by the monumental love and support of my wife, family and close friends' while undergoing treatment. Murnaghan, 67, also urged men to get checked for prostate cancer and to demand that the NHS does more to screen for the disease. The presenter wrote: 'Needless to say my message to all men over 50, in high-risk groups, or displaying symptoms, is get yourself tested and campaign for routine prostate screening by the NHS. 'Early detection is crucial. And be aware, this disease can sometimes progress rapidly without obvious symptoms.' Murnaghan added that he was responding well to 'excellent' treatment, and thanked the 'outstanding' medical team that had been caring for him. Charity bike ride The former host of the quiz show Eggheads also announced his intention to take part in Sir Chris Hoy's new Tour de 4 charity bike ride, born from the Olympic champion's 'vision to change perceptions around stage four cancer following his own diagnosis'. The charity ride will take place in Glasgow in September. Murnaghan's lengthy career has spanned all of Britain's major broadcasters. In 1997, he was working for ITN when he had a call in the middle of the night from editors demanding that he rush to the studio to break the news of the death of Diana, Princess of Wales. Working at Sky News 25 years later, Murnaghan announced the death of Elizabeth II. In 2023, Murnaghan left after 15 years with the broadcaster, delivering a final address in which he said: 'Thank you so much for putting up with me and supporting me so resolutely. 'I hope that I have managed to serve you well, it has been an absolute privilege.' He then showed the viewer his programme notes, before throwing them over his shoulder, saying: 'You stay classy planet Earth.'